INACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) BY ULTRAVIOLET AND X-IRRADIATION

被引:16
|
作者
HENDERSON, EE [1 ]
TUDOR, G [1 ]
YANG, JY [1 ]
机构
[1] TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140
关键词
D O I
10.2307/3578438
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Here we report the kinetics of inactivation of HIV-1 by ultraviolet (UV) or X irradiation. Inactivation of HIV-1 by UV irradiation followed quasi first-order, i.e., single-hit, kinetics. The LD37 for inactivation of syncytia formation in SupT1 cells by limiting dilutions was approximately 780 J/m2. The LD37 for inactivation of HIV-1-induced syncytia by UV irradiation was nearly identical when measured in UV repair-proficient and deficient lymphoblastoid cell lines (LCLs), demonstrating that immediate host cell reactivation (repair) of UV damage in the HIV-1 genome does not occur. The ability of HIV-1 to induce the accumulation of reverse transcriptase activity showed similar dose-dependent inhibition by UV irradiation (LD37, 845 J/m2). Inactivation of HIV-1-induced syncytia formation by X rays also approached first-order kinetics. The LD37 for syncytia formation as measured by limiting dilutions was approximately 3 x 103 Gy. HIV-1-induced accumulation of reverse transcriptase activity was slightly more resistant to inactivation by X rays, with an LD37 of approximately 4.5 x 103 Gy. Syncytia-forming ability was still present in HIV-1 preparations X-irradiated with 1.6 x 104 Gy. For the first time, we utilized the polymerase chain reaction (PCR) to measure the effects of radiation on virus replication. A decrease in the presence of the HIV-1 DNA could be detected by PCR in PBL cultures infected with UV- and X-irradiated virus. It required 12.96 J/m2 to eliminate the signal specific for HIV-1 DNA completely. The ability of HIV-1 to establish long-term infection in LCLs was also resistant to UV and X irradiation. Only linear and circular forms of HIV-1 DNA could be detected in LCLs established from PBL cultures infected with UV-irradiated virus. The significance of the relative resistance of HIV-1 to inactivation by UV and X irradiation is discussed.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [21] A ROLE FOR THE ASPARTYL PROTEASE FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN THE ORCHESTRATION OF VIRUS ASSEMBLY
    NAVIA, MA
    MCKEEVER, BM
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 616 : 73 - 85
  • [22] Human immunodeficiency virus type-1 (HIV-1) subtypes in Jamaica
    Heslop, OD
    Smikle, M
    Deer, D
    Christian, NA
    Vickers, IE
    Harvey, KM
    Figueroa, JP
    Christie, CDC
    Bain, B
    Barton, EN
    WEST INDIAN MEDICAL JOURNAL, 2005, 54 (05): : 279 - 282
  • [23] COMPARISON OF COMMERCIAL KITS FOR THE DETECTION OF ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN NIGERIA
    CHIKWEM, JO
    MOHAMMED, I
    OLA, TO
    EAST AFRICAN MEDICAL JOURNAL, 1990, 67 (03) : 209 - 213
  • [24] THE DOT-IMMUNOBINDING TECHNIQUE IN DETECTION OF ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
    JANDA, WM
    WILCOSKI, LM
    TERRILE, L
    MANDEL, K
    NOVAK, D
    STEVENS, JM
    LABORATORY MEDICINE, 1995, 26 (02) : 131 - &
  • [25] EPOXY AND LOWICRYL EMBEDDING FOR LOCALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEINS IN VIRIONS
    GOTO, T
    MORITA, C
    SUKENAGA, A
    NAKAI, M
    IKUTA, K
    KATO, S
    JOURNAL OF ELECTRON MICROSCOPY, 1990, 39 (04): : 280 - 280
  • [26] A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION-ENHANCING FACTOR IN SEROPOSITIVE SERA
    ROBINSON, WE
    MONTEFIORI, DC
    MITCHELL, WM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 693 - 699
  • [27] ABNORMALITIES OF MEASLES ANTIBODY-RESPONSE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
    BRUNELL, PA
    VIMAL, V
    SANDHU, M
    COURVILLE, TM
    DAAR, E
    ISRAELE, V
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (05): : 540 - 548
  • [28] TSAO DERIVATIVES - HIGHLY SPECIFIC INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REPLICATION
    CAMARASA, MJ
    PEREZPEREZ, MJ
    VELAZQUEZ, S
    SANFELIX, A
    ALVAREZ, R
    INGATE, S
    JIMENO, ML
    KARLSSON, A
    DECLERCQ, E
    BALZARINI, J
    NUCLEOSIDES & NUCLEOTIDES, 1995, 14 (3-5): : 585 - 594
  • [29] UNLINKED ANONYMOUS SCREENING OF ANTENATAL PATIENTS FOR ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)
    CHEW, CB
    DOWNIE, JC
    CUNNINGHAM, AL
    MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (11) : 693 - 696
  • [30] 3-D QSAR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)PROTEASE INHIBITORS
    WALLER, CL
    OPREA, TI
    MARSHALL, GR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 87 - MEDI